Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James B Lorens

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
Frontiers in Immunology|May 16, 2022
Dissecting the Role of AXL in Cancer Immune Escape and Resistance to Immune Checkpoint InhibitionAgnete S T Engelsen, Maria L Lotsberg, Raefa Abou Khouzam, et al.
BMC Biotechnology|June 23, 2014
Flow cytometry-based functional selection of RNA interference triggers for efficient epi-allelic analysis of therapeutic targetsDavid R Micklem, Magnus Blø, Petra Bergström, et al.
Plos One|June 5, 2009
Mural cell associated VEGF is required for organotypic vessel formationLasse Evensen, David R Micklem, Anna Blois, et al.
Molecular Imaging|May 30, 2007
In vivo optical imaging of acute myeloid leukemia by green fluorescent protein: time-domain autofluorescence decoupling, fluorophore quantification, and localizationEmmet McCormack, David R Micklem, Lars-Erik Pindard, et al.
Bone Reports|June 14, 2019
Adenoviral mediated mono delivery of BMP2 is superior to the combined delivery of BMP2 and VEGFA in bone regeneration in a critical-sized rat calvarial bone defectSunita Sharma, Ying Xue, Zhe Xing, et al.
International Journal of Cancer|December 7, 2006
RACK1 regulates Ki-Ras-mediated signaling and morphological transformation of NIH 3T3 cellsBodil Bjørndal, Line M Myklebust, Ken Roger Rosendal, et al.
Disease Models & Mechanisms|March 3, 2021
High-dimensional immunotyping of tumors grown in obese and non-obese miceCara E Wogsland, Hilde E Lien, Line Pedersen, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2012
A combined targeted/phenotypic approach for the identification of new antiangiogenics agents active on a zebrafish model: from in silico screening to cyclodextrin formulationMarco Radi, Lasse Evensen, Elena Dreassi, et al.
Molecular Cancer Therapeutics|November 20, 2025
AXL kinase inhibition promotes cytosolic DNA sensor cGAS activity and sensitizes poorly immunogenic tumors to chemo-immunotherapySushil Dhakal, Muntequa I Siraji, Sturla M Grøndal, et al.
Journal of Tissue Engineering and Regenerative Medicine|September 25, 2010
Efficient in vivo vascularization of tissue-engineering scaffoldsAnja Hegen, Anna Blois, Crina E Tiron, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Frontiers in Immunology|May 16, 2022
Dissecting the Role of AXL in Cancer Immune Escape and Resistance to Immune Checkpoint InhibitionAgnete S T Engelsen, Maria L Lotsberg, Raefa Abou Khouzam, et al.
BMC Biotechnology|June 23, 2014
Flow cytometry-based functional selection of RNA interference triggers for efficient epi-allelic analysis of therapeutic targetsDavid R Micklem, Magnus Blø, Petra Bergström, et al.
Plos One|June 5, 2009
Mural cell associated VEGF is required for organotypic vessel formationLasse Evensen, David R Micklem, Anna Blois, et al.
Molecular Imaging|May 30, 2007
In vivo optical imaging of acute myeloid leukemia by green fluorescent protein: time-domain autofluorescence decoupling, fluorophore quantification, and localizationEmmet McCormack, David R Micklem, Lars-Erik Pindard, et al.
Bone Reports|June 14, 2019
Adenoviral mediated mono delivery of BMP2 is superior to the combined delivery of BMP2 and VEGFA in bone regeneration in a critical-sized rat calvarial bone defectSunita Sharma, Ying Xue, Zhe Xing, et al.
International Journal of Cancer|December 7, 2006
RACK1 regulates Ki-Ras-mediated signaling and morphological transformation of NIH 3T3 cellsBodil Bjørndal, Line M Myklebust, Ken Roger Rosendal, et al.
Disease Models & Mechanisms|March 3, 2021
High-dimensional immunotyping of tumors grown in obese and non-obese miceCara E Wogsland, Hilde E Lien, Line Pedersen, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2012
A combined targeted/phenotypic approach for the identification of new antiangiogenics agents active on a zebrafish model: from in silico screening to cyclodextrin formulationMarco Radi, Lasse Evensen, Elena Dreassi, et al.
Molecular Cancer Therapeutics|November 20, 2025
AXL kinase inhibition promotes cytosolic DNA sensor cGAS activity and sensitizes poorly immunogenic tumors to chemo-immunotherapySushil Dhakal, Muntequa I Siraji, Sturla M Grøndal, et al.
Journal of Tissue Engineering and Regenerative Medicine|September 25, 2010
Efficient in vivo vascularization of tissue-engineering scaffoldsAnja Hegen, Anna Blois, Crina E Tiron, et al.
Pageof 9